🔍 Rechercher dans les archives
📊 2,262 articles
archivé(s)
Page 114 / 114
First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study
MELBOURNE, Australia and INDIANAPOLIS, Jan. 16, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announc...
UCL Breakthrough Spurs New NHS Prostate Cancer Treatment - Mirage News
UCL Breakthrough Spurs New NHS Prostate Cancer Treatment Mirage NewsLife-extending prostate cancer drug to be offered to thousands in England BBCNHS e...